Systematic Review of Ovarian Activity and Potential for Embryo Formation and Loss during the Use of Hormonal Contraception

被引:4
|
作者
Harrison, Donna [1 ]
Buskmiller, Cara [2 ]
Chireau, Monique [4 ]
Ruppersberger, Lester A. [5 ]
Yeung, Patrick P., Jr. [3 ]
机构
[1] Amer Assoc Prolife Obstetricians & Gynecologists, POB 395, Eau Claire, MI 49111 USA
[2] St Louis Univ, Obstet & Gynecol, St Louis, MO 63103 USA
[3] St Louis Univ, Dept Obstet Gynecol & Womens Hlth, St Louis, MO 63103 USA
[4] Duke Univ, Dept Obstet & Gynecol, Obstet & Gynecol, Durham, NC USA
[5] Catholic Med Assoc, Bala Cynwyd, PA USA
来源
LINACRE QUARTERLY | 2018年 / 85卷 / 04期
关键词
Bioethics of emergency contraceptives; Contraception; Emergency contraception; Ethics of reproduction; Fertility awareness; Oral contraception; Plan B; Rape protocols; Rights of conscience;
D O I
10.1177/0024363918815611
中图分类号
R-052 [医学伦理学];
学科分类号
0101 ; 120402 ;
摘要
The purpose of this review was to determine whether there is evidence that ovulation can occur in women using hormonal contraceptives and whether these drugs might inhibit implantation. We performed a systematic review of the published English-language literature from 1990 to the present which included studies on the hormonal milieu following egg release in women using any hormonal contraceptive method. High circulating estrogens and progestins in the follicular phase appear to induce dysfunctional ovulation, where follicular rupture occurs but is followed by low or absent corpus luteum production of progesterone. Hoogland scoring of ovulatory activity may inadvertently obscure the reality of ovum release by limiting the term "ovulation" to those instances where follicular rupture is followed by production of a threshold level of luteal progesterone, sufficient to sustain fertilization, implantation, and the end point of a positive beta-human chorionic gonadotropin. However, follicular ruptures and egg release with subsequent low progesterone output have been documented in women using hormonal contraception. In the absence of specific ovulation and fertilization markers, follicular rupture should be considered the best marker for egg release and potential fertilization. Women using hormonal contraceptives may produce more eggs than previously described by established criteria; moreover, suboptimal luteal progesterone production may be more likely than previously acknowledged, which may contribute to embryo loss. This information should be included in informed consent for women who are considering the use of hormonal contraception. For this study, the authors looked at English-language research articles that focused on how hormonal birth control, such as the birth control pill, may affect very early human embryos. The authors found that abnormal ovulation, or release of an egg followed by abnormal hormone levels, may often occur in women using hormonal birth control. This may increase the number of very early human embryos who are lost before a pregnancy test becomes positive. For women who are thinking about using hormonal birth control, this is important information to consider.
引用
收藏
页码:453 / 469
页数:17
相关论文
共 50 条
  • [31] Residual ovarian activity during oral steroid contraception
    van Heusden, AM
    Fauser, BCJM
    HUMAN REPRODUCTION UPDATE, 2002, 8 (04) : 345 - 358
  • [32] THE EFFECT OF HORMONAL CONTRACEPTION USE ON OVARIAN RESERVE MARKERS IN THOSE SEEKING INFERTILITY EVALUATION
    Siegel, Dana R.
    Fresia, Joellen
    Fought, Angela
    Sheeder, Jeanelle
    Hampanda, Karen
    Appiah, Leslie Coker
    FERTILITY AND STERILITY, 2022, 118 (04) : E45 - E45
  • [33] Hormonal contraception among electronic cigarette users and cardiovascular risk: a systematic review
    Riley, Halley E. M.
    Berry-Bibee, Erin
    England, Lucinda J.
    Jamieson, Denise J.
    Marchbanks, Polly A.
    Curtis, Kathryn M.
    CONTRACEPTION, 2016, 93 (03) : 190 - 208
  • [34] Pharmacist-prescribed hormonal contraception services: A systematic review of implementation studies
    Beal, Jenny L.
    Reed, Jason B.
    Stone, Rebecca H.
    Satterfield, Kennedi G.
    Meredith, Ashley H.
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2022, 5 (01): : 85 - 98
  • [35] Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review
    Curtis, Kathryn M.
    Nanda, Kavita
    Kapp, Nathalie
    AIDS, 2009, 23 : S55 - S67
  • [36] The Relationship Between Progestin Hormonal Contraception and Depression: A Systematic Review EDITORIAL COMMENT
    Worly, Brett L.
    Gur, Tamar L.
    Schaffir, Jonathan
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2018, 73 (10) : 584 - 585
  • [37] Use of hormonal contraceptives in perimenopause: A systematic review
    Guerin, Julie
    Engelmann, Alexandra
    Mattamana, Meena
    Borgelt, Laura M.
    PHARMACOTHERAPY, 2022, 42 (02): : 154 - 164
  • [38] Treatment of unscheduled bleeding in women using extended- or continuous-use combined hormonal contraception: a systematic review
    Godfrey, Emily M.
    Whiteman, Maura K.
    Curtis, Kathryn M.
    CONTRACEPTION, 2013, 87 (05) : 567 - 575
  • [39] Drug interactions between non-rifamycin antibiotics and hormonal contraception: a systematic review
    Simmons, Katharine B.
    Haddad, Lisa B.
    Nanda, Kavita
    Curtis, Kathryn M.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 218 (01) : 88 - +
  • [40] Menstrual Cycle Phase, Hormonal Contraception, and Alcohol Consumption in Premenopausal Females: A Systematic Review
    Warren, Jasmine G. G.
    Fallon, Victoria M. M.
    Goodwin, Laura
    Gage, Suzanne H. H.
    Rose, Abigail K. K.
    FRONTIERS IN GLOBAL WOMENS HEALTH, 2021, 2